Gene · 11255
Papers1,482
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,482
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease. | Adv Neurobiol | 2023 | 37480459 | PubTator, text mining | PubMed |
| Neurotransmitter and receptor systems in the subthalamic nucleus. | Brain Struct Funct | 2023 | 37479801 | PubTator, text mining | PubMed |
| Effect of moderate prenatal ethanol exposure on the differential expression of two histamine H3 receptor isoforms in different brain regions of adult rat offspring. | Front Neurosci | 2023 | 37449267 | PubTator, text mining | PubMed |
| Histaminergic regulation of food intake. | Front Endocrinol (Lausanne) | 2023 | 37448468 | PubTator, text mining | PubMed |
| Cerebral chemoarchitecture shares organizational traits with brain structure and function. | Elife | 2023 | 37440423 | PubTator, text mining | PubMed |
| Dual Piperidine-Based Histamine H3 and Sigma-1 Receptor Ligands in the Treatment of Nociceptive and Neuropathic Pain. | J Med Chem | 2023 | 37418295 | PubTator, text mining | PubMed |
| Targeting LncRNA LLNLR-299G3.1 with antisense oligonucleotide inhibits malignancy of esophageal squamous cell carcinoma cells in vitro and in vivo. | Oncol Res | 2023 | 37415734 | PubTator, text mining | PubMed |
| Virtual Screening of a Marine Natural Product Database for In Silico Identification of a Potential Acetylcholinesterase Inhibitor. | Life (Basel) | 2023 | 37374081 | PubTator, text mining | PubMed |
| Inflammatory Bowel Disease: Crosstalk between Histamine, Immunity, and Disease. | Int J Mol Sci | 2023 | 37373085 | PubTator, text mining | PubMed |
| Molecular Mechanism and Clinical Effects of Probiotics in the Management of Cow's Milk Protein Allergy. | Int J Mol Sci | 2023 | 37372929 | PubTator, text mining | PubMed |
| The histamine system and cognitive function: An in vivo H3 receptor PET imaging study in healthy volunteers and patients with schizophrenia. | J Psychopharmacol | 2023 | 37329185 | PubTator, text mining | PubMed |
| Histamine H1- and H4-receptor expression in human colon-derived cell lines. | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 37300703 | PubTator, text mining | PubMed |
| The Coming of Age of the P2X7 Receptor in Diagnostic Medicine. | Int J Mol Sci | 2023 | 37298415 | PubTator, text mining | PubMed |
| Detecting and measuring of GPCR signaling - comparison of human induced pluripotent stem cells and immortal cell lines. | Front Endocrinol (Lausanne) | 2023 | 37293485 | PubTator, text mining | PubMed |
| Guanidines: Synthesis of Novel Histamine H3R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect. | Pharmaceuticals (Basel) | 2023 | 37242458 | PubTator, text mining | PubMed |
| Trisubstituted 1,3,5-Triazines as Histamine H4 Receptor Antagonists with Promising Activity In Vivo. | Molecules | 2023 | 37241939 | PubTator, text mining | PubMed |
| Migraine, Allergy, and Histamine: Is There a Link? | J Clin Med | 2023 | 37240671 | PubTator, text mining | PubMed |
| Using genomics, morphometrics, and environmental niche modeling to test the validity of a narrow-range endemic snail, Pateranantahala (Gastropoda, Polygyridae). | Zookeys | 2023 | 37234252 | PubTator, text mining | PubMed |
| Pitolisant: Pediatric First Approval. | Paediatr Drugs | 2023 | 37233887 | PubTator, text mining | PubMed |
| Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion. | Mol Med | 2023 | 37217845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11255/papers?page=8